Trials / Completed
CompletedNCT03148236
Vitamin C in Atrial Fibrillation Ablation
Pilot Study of the Safety and Efficacy of Intravenous Vitamin C in Patients Undergoing Atrial Fibrillation Ablation
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Virginia Commonwealth University · Academic / Other
- Sex
- All
- Age
- 21 Years
- Healthy volunteers
- Not accepted
Summary
Single-center, double-blinded, randomized, controlled safety and feasibility pilot study of high dose IV ascorbic acid (200mg/kg) over 24 hours, divided into four doses and administered every six hours with a 30 minute IV infusion time per dose, compared to matched placebo infusion
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Vitamin C | 200mg/kg/day split into 4 doses infused every six hours over 30 minutes in 50ml D5W |
| OTHER | Placebo | 50mL infused over 30 minutes |
Timeline
- Start date
- 2017-09-18
- Primary completion
- 2018-03-13
- Completion
- 2018-03-13
- First posted
- 2017-05-10
- Last updated
- 2019-04-16
- Results posted
- 2019-04-16
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03148236. Inclusion in this directory is not an endorsement.